NASDAQ:CERC
Delisted
Cerecor Inc. Stock News
$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022
Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.
07:30am, Thursday, 26'th Aug 2021
WAYNE, Pa. and ROCKVILLE, Md., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializ
Cerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates
04:01pm, Monday, 02'nd Aug 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization o
Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance
07:30am, Monday, 02'nd Aug 2021
Achieved performance milestone with positive initial results from its Phase 1b trial of CERC-002 in moderate-to- severe Crohn's Disease who had previously failed three or more lines of biologics thera
Cerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated Patients
06:16am, Tuesday, 27'th Jul 2021
Cerecor Inc (NASDAQ: CERC) announced initial results from a Phase 1b proof-of-concept study evaluating CERC-002 in adult patients with moderate to severe Crohn's disease (CD). CERC-002 is an invest
Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets
07:30am, Wednesday, 23'rd Jun 2021
Cerecor completes divestiture of non-core neurology pipeline assets as it increases its focus on immunology, immuno-oncology, and rare genetic disorders Cerecor completes divestiture of non-core neuro
Top Penny Stocks to Buy Moving in Premarket? Check These 3 Out
09:27am, Tuesday, 11'th May 2021
These 3 penny stocks made big moves in pre-market trading; are they worth it? The post Top Penny Stocks to Buy Moving in Premarket?
Cerecor Shares Gain After FDA Fast Track Review Tag For CERC-002 In Hospitalized COVID-19 Patients
09:15am, Tuesday, 11'th May 2021
The FDA has granted Fast Track designation to Cerecor Inc's (NASDAQ: CERC) CERC-002 to treat hospitalized patients with COVID-19. CERC-002 is a first-in-class fully human monoclonal antibody targ
Cerecor's investigational COVID-19 therapy gets Fast Track designation from the FDA
07:33am, Tuesday, 11'th May 2021
Shares of Cerecor Inc. gained 17.3% in premarket trading on Tuesday after the company said its experimental COVID-19 drug had received a Fast Track designation from the Food and Drug Administration. T
A Small Biotech Stock That Has All The Right Ingredients for a Big 2021 Breakout
10:10am, Friday, 30'th Apr 2021
$230 million biopharmaceutical company Cerecor (CERC) may end up being the industry's biggest winner on Wall Street over the next six months. The post A Small Biotech Stock That Has All The Right Ingr
Cerecor Inks New Global License Agreement With Kyowa Kirin For CERC-002
08:33am, Monday, 29'th Mar 2021
Cerecor Inc's (NASDAQ: CERC) wholly-owned subsidiary, Aevi Genomic Medicine LLC, has entered into an expanded agreement with Kyowa Kirin Co Ltd (OTCMKTS: KYKOF) for exclusive worldwide rights to
Cerecor Reports 2020 Financial Results and Provides Business Updates
04:01pm, Monday, 08'th Mar 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., March 08, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of t
Cerecor to Present at Upcoming Investor Conferences
07:00am, Thursday, 04'th Mar 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization
CERC Stock Price Increases Over 10% Pre-Market: Why It Happened
07:54am, Tuesday, 02'nd Mar 2021
The stock price of Cerecor Inc. (NASDAQ:CERC) is trading at over 10% pre-market. This is why it happened.
Cerecor Announces Fast Track Designation for CERC-803 for the Treatment of Leukocyte Adhesion Deficiency Type II
07:00am, Tuesday, 02'nd Feb 2021
ROCKVILLE, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and
Cerecor Announces Proceeds from Option to Purchase Additional Shares of Common Stock Bringing Public Offering Proceeds to $40.7 Million
07:00am, Wednesday, 20'th Jan 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (“Cerecor”; NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commerci